Rates and Causes of End-Stage Renal Disease in Navajo Indians, 1971-1985
AUTOR(ES)
Megill, Donald M.
RESUMO
The rates of end-stage renal disease are much increased in American Indians, but no longitudinal study of its rates and causes has been undertaken in any tribe. This 15-year study of rates and causes of treated end-stage renal disease in the Navajo, the largest Indian tribe, supplies an important model on which to base projections and plan interventions. Treated end-stage renal disease in Navajos has increased to an age-adjusted incidence 4 times that in whites in the United States. Diabetic nephropathy accounted for 50% of all new cases in 1985, with an incidence 9.6 times that in US whites, and was due entirely to type II disease. Glomerulonephritis caused end-stage renal disease in Navajos at a rate at least 1.8 times that in US whites and afflicted a much younger population. The predominant form was mesangial proliferative glomerulonephritis associated with an immune complex deposition. Renal disease of unknown etiology, which probably includes much silent glomerulonephritis, accounted for 20% of all new cases. The aggregate Navajo population with end-stage renal disease was 9 years younger than its US counterpart.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1026368Documentos Relacionados
- End-stage renal disease patients up nearly 19%
- Pericardial effusions in patients with end-stage renal disease.
- Assessment of quality of life in end-stage renal disease.
- Hemodialysis improves endothelial venous function in end-stage renal disease
- Hemodialysis improves endothelial venous function in end-stage renal disease